Roche vs Wipro: Founders, CEOs and History
Roche was founded in 1896 by Fritz Hoffmann-La Roche and is led by Thomas Schinecker. Wipro was founded in 1945 by Mohamed Hasham Premji and is led by Srini Pallia.
Company facts
Founders
Roche
Fritz Hoffmann-La Roche
Fritz Hoffmann-La Roche (1868-1920) founded F. Hoffmann-La Roche & Co. in Basel on 1 October 1896, at age 28.
Wipro
Mohamed Hasham Premji
Mohamed Hasham Premji incorporated Western India Vegetable Products Limited in Amalner, Maharashtra in 1945 to produce vegetable oil.
CEOs and their tenures
Roche
- Severin Schwan2008–2023
Chief Executive Officer
Serving as CEO from 2008 to 2023, he cemented Roche's absolute dominance in global oncology and highly advanced diagnostics before moving to Chairman of the Board.
Source - Thomas Schinecker2023–present
Chief Executive Officer
Under Schinecker, Roche returned to growth after the COVID testing decline: 2025 sales rose 7% at constant rates to ~$73.8 billion (CHF 61.5 billion) and 12 late-stage studies read out positively that year.
Source
Wipro
- Rishad Premji2019–present
Executive Chairman
As Executive Chairman, he enforced a strict return-to-office mandate and publicly cracked down on employee moonlighting, prioritizing utilization rates over aggressive headcount growth.
Source - Thierry Delaporte2020–2024
CEO and Managing Director
He decentralized Wipro's operating model into four massive strategic market units, though he struggled to match the organic growth rates of rivals like TCS and Infosys before stepping down.
Source - Srini Pallia2024–present
Chief Executive Officer and Managing Director
Leads Wipro's push for large deals, consulting-led selling, and AI-enabled delivery.
Source
Timeline: Roche and Wipro side by side
1896Roche
F. Hoffmann-La Roche Founded in Basel
Fritz Hoffmann-La Roche founds the enterprise in Basel, Switzerland, pioneering mass-manufactured, chemically standardized prescription pharmaceuticals.
1898Roche
Commercial Breakthrough with Sirolin
Roche launches non-prescription cough syrup Sirolin, achieving widespread international distribution and financing early clinical laboratories.
1934Roche
First Industrial Synthesis of Vitamin C
Roche becomes the first company to mass-produce synthetic Vitamin C (Redoxon) at industrial scale, anchoring decades of high-margin global cash flow.
1945Wipro
Incorporated as Western India Vegetable Products
Mohamed Hasham Premji sets up a vegetable oil business in Amalner, Maharashtra.
1963Roche
Launch of Valium (Diazepam)
Roche introduces Valium, which becomes the world's most widely prescribed psychotropic medication and establishes global pharmaceutical leadership.
1966Wipro
Azim Premji takes over
After his father's death, 21-year-old Azim Premji leaves Stanford to run the company.
1968Roche
Establishment of Roche Diagnostics
Roche launches its dedicated diagnostic division, laying the foundation to become the world's preeminent in-vitro diagnostics (IVD) provider.
2000Wipro
NYSE listing
Wipro lists American Depositary Shares on the New York Stock Exchange under the ticker WIT.
2007Wipro
Acquired Infocrossing
Wipro Limited acquired Infocrossing for $600 million.
2008Roche
Severin Schwan becomes CEO
Severin Schwan became CEO of F. Hoffmann-La Roche in 2008. Led Roche for 14 years; handed over to Thomas Schinecker in March 2023 and became chairman.
2009Roche
Full Acquisition of Genentech for $46.8 Billion
Roche completes its historic $46.8 billion buyout of American biotechnology pioneer Genentech, securing market leadership in oncology biologics.
2013Wipro
Non-IT businesses demerged
Consumer care, lighting, and infrastructure engineering businesses move to the unlisted Wipro Enterprises.
2018Roche
Foundation Medicine & Flatiron Health Acquisitions
Roche acquires Foundation Medicine and Flatiron Health, integrating real-world oncology data analytics and genomic profiling into personalized healthcare.
2019Wipro
Rishad Premji becomes Executive Chairman
Azim Premji retires from the executive role and his son Rishad Premji takes over as chairman.
2021Wipro
Capco acquisition completed
Wipro completes its $1.45 billion acquisition of financial services consultancy Capco.
2022Wipro
Acquired Rizing
Wipro Limited acquired Rizing for $540 million.
2023Roche
Acquired Telavant
F. Hoffmann-La Roche acquired Telavant for $7.1 billion. Roche paid $7.1 billion upfront for Telavant to gain US and Japan rights to the anti-TL1A antibody RVT-3101 (afimkibart) for inflammatory bowel disease.
2024Wipro
Srini Pallia named CEO
Srini Pallia succeeds Thierry Delaporte as CEO and Managing Director in April 2024.
2025Roche
Group Sales Reach CHF 61.5 Billion
Under CEO Thomas Schinecker, Roche delivers group sales of ~$73.8 billion (CHF 61.5 billion), driven by ~$57.2B (CHF 47.7B) in Pharmaceuticals and ~$16.6B (CHF 13.8B) in Diagnostics.
2026Wipro
Rs 150 billion buyback approved
Alongside FY2026 results in April 2026, the board approves a Rs 150 billion share buyback.
Acquisitions
Roche
- PathAI2026$1.1B
- 89bio2025$3.5B
- Telavant2023$7.1B
- Carmot Therapeutics2023$2.7B
- Foundation Medicine2018$2.4B
- ForSight VISION42017Undisclosed
Wipro
- Harman Digital Transformation Solutions2025$375M
- Rizing2022$540M
- Capco2021$1.4B
- Appirio2016$500M
- Infocrossing2007$600M
Questions about Roche vs Wipro
Who is the CEO of F. Hoffmann-La Roche AG and Wipro Limited?
F. Hoffmann-La Roche AG is led by Thomas Schinecker and Wipro Limited is led by Srini Pallia. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was F. Hoffmann-La Roche AG founded vs Wipro Limited?
F. Hoffmann-La Roche AG was founded in 1896 — 49 years before Wipro Limited, which was founded in 1945. F. Hoffmann-La Roche AG's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Wipro Limited.
How many employees does F. Hoffmann-La Roche AG have compared to Wipro Limited?
F. Hoffmann-La Roche AG employs approximately 112,774 people, while Wipro Limited employs approximately 228,000. Wipro Limited has the larger workforce at 228,000 employees, compared to F. Hoffmann-La Roche AG's 112,774. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are F. Hoffmann-La Roche AG and Wipro Limited headquartered?
F. Hoffmann-La Roche AG is headquartered in Switzerland and Wipro Limited is headquartered in India. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded F. Hoffmann-La Roche AG and Wipro Limited?
F. Hoffmann-La Roche AG was founded by Fritz Hoffmann-La Roche. Wipro Limited was founded by Mohamed Hasham Premji.
Which company has a longer operating history — F. Hoffmann-La Roche AG or Wipro Limited?
F. Hoffmann-La Roche AG has been operating for approximately 130 years, making it the more established of the two companies. Wipro Limited has been in operation for around 81 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Roche vs Wipro overview